Tumor necrosis factor-α concentrations in the aqueous humor of patients with glaucoma

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 2, 2010, Pages 903-906

  Sawada, Hideko ^a   Fukuchi, Takeo ^a   Tanaka, Takayuki ^a   Abe, Haruki ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

AGED; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXFOLIATION SYNDROME; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; SENILE CATARACT; CLASSIFICATION; METABOLISM;

AGED; AQUEOUS HUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77449132674     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4247     Document Type: Article

References (27)

1. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods, and baseline characteristics of study patients. Control Clin Trials. 1994;15:299-325.
2. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000; 130:429-440.
3. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 1994;25(7):1481-1488.
4. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res. 2006;25:490-513.
5. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
6. Tezel G, Wax MB. Increased production of tumor necrosis factor-α by glial cells exposed to stimulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci. 2000;20:8693-8700.
7. Zorena K, Mysliwska J, Mysliwiec M, et al. Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children. Mediators of Inflammation. 2007;92196:1-5.
8. Doganay S, Evereklioglu C, Er H, et al. Comparison of serum NO, TNF-α, IL-1β, slL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye. 2002;16:163-170.
9. Clark IA. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 2007;18:335-343.
10. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-α: a mediator of focal ischemic brain injury. Stroke. 1997;28:1233-1244.
11. Muñoz-Fernández MA, Fresno M. The role of tumor necrosis factor, interleukin 6, interferon-γ, and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol. 1998;56:307-340.
12. Ertel W, Keel M, Bonaccio M, et al. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma. 1995;39:879-887.
13. Shohami E, Bass R, Wallach D, Yamin A, Gallily R. Inhibition of tumor necrosis factor alpha (tnf-α) activity in rat brain is associated with cerebroprotection after closed head injury. J Cerebr Blood Flow Metab. 1996;16:378-384.
14. Sugita S, Takase H, Taguchi C, Mochizuki M. The role of soluble TNF receptors for TNF-alpha in uveitis. Invest Ophthalmol Vis Sci. 2007;48:3246-3252.
15. Nakazawa T, Nakazawa C, Matsubara A, et al. Tumor necrosis factor-α mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci. 2006; 26:12633-12641.
16. Butt AM, Jenkins HG. Morphological changes in oligodendrocytes in the intact mouse optic nerve following intravitreal injection of tumor necrosis factor. J Neuroimmunol. 1994;51:27-33.
17. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci. 2005;6:889-898.
18. Yan X, Tezel G, Wax B, Edward P. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmology. 2000;118:666-673.
19. Tezel G, Li LY, Patil RV, Wax MB. TNF-α and TNF-α receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2001;42:1787-1794.
20. Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neuroscience Res. 2001;64(5):523-532.
21. Lieberman AP, Pitha PM, Shin HS, Shin ML. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA. 1989;86:6348-6352.
22. Cotinet A, Goureau O, Thillaye-Goldenberg B, Naud MC, de Kozak Y. Differential tumor necrosis factor and nitric oxide production in retinal Müller glial cells from C3H/HeN and C3H/HeJ mice. Ocul Immunol Inflamm. 1997;5:111-116.
23. Chen KH, Wu CC, Roy S, Lee SM, Liu JH. Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci. 1999;40:2627-2632.
24. Franks WA, Limb GA, Stanford MR, et al. Cytokines in human intraocular inflammation. Curr Eye Res. 1992;11:187-191.
25. Cordeiro MF, Guo L, Luong V, et al. Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci USA. 2004;101:13352-13356.
26. Yoshida M, Takeuchi M, Streilein JW. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Invest Ophthalmol Vis Sci. 2000;41:811-821.
27. Drescher KM, Whittum-Hudson JA. Modulation of immune-associated surface markers and cytokine production by murine retinal glial cells. J Neuroimmunol. 1996;64:71-81.